These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8854030)

  • 1. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.
    Schwendeman SP; Costantino HR; Gupta RK; Tobio M; Chang AC; Alonso MJ; Siber GR; Langer R
    Dev Biol Stand; 1996; 87():293-306. PubMed ID: 8854030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems.
    Dong WY; Körber M; López Esguerra V; Bodmeier R
    J Control Release; 2006 Oct; 115(2):158-67. PubMed ID: 16963145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategies for the microencapsulation of tetanus vaccine.
    Schwendeman SP; Tobío M; Joworowicz M; Alonso MJ; Langer R
    J Microencapsul; 1998; 15(3):299-318. PubMed ID: 9608394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
    Gupta RK; Griffin P; Rivera R; Siber GR
    Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of tetanus toxoid encapsulated in PLGA microspheres.
    Jiang W; Schwendeman SP
    Mol Pharm; 2008; 5(5):808-17. PubMed ID: 18710256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres.
    Walker KB; Xing DK; Sesardic D; Corbel MJ
    Dev Biol Stand; 1998; 92():259-67. PubMed ID: 9554281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
    Jung T; Koneberg R; Hungerer KD; Kissel T
    Int J Pharm; 2002 Mar; 234(1-2):75-90. PubMed ID: 11839439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen.
    Chang AC; Gupta RK
    J Pharm Sci; 1996 Feb; 85(2):129-32. PubMed ID: 8683435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
    Gupta RK; Chang AC; Siber GR
    Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active self-healing encapsulation of vaccine antigens in PLGA microspheres.
    Desai KG; Schwendeman SP
    J Control Release; 2013 Jan; 165(1):62-74. PubMed ID: 23103983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
    Sánchez A; Villamayor B; Guo Y; McIver J; Alonso MJ
    Int J Pharm; 1999 Aug; 185(2):255-66. PubMed ID: 10460920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
    Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
    Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres.
    Pérez C; Griebenow K
    Biotechnol Bioeng; 2003 Jun; 82(7):825-32. PubMed ID: 12701149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
    Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
    Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
    Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
    J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
    Kim JH; Taluja A; Knutson K; Han Bae Y
    J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.
    Tobío M; Nolley J; Guo Y; McIver J; Alonso MJ
    Pharm Res; 1999 May; 16(5):682-8. PubMed ID: 10350011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internal morphology of poly(D,L-lactide-co-glycolide) BCNU-loaded microspheres. Influence on drug stability.
    Painbeni T; Venier-Julienne MC; Benoit JP
    Eur J Pharm Biopharm; 1998 Jan; 45(1):31-9. PubMed ID: 9689533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.